Your browser doesn't support javascript.
loading
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
Ledet, Elisa M; Burgess, Earle F; Sokolova, Alexandra O; Jaeger, Ellen B; Hatton, Whitley; Moses, Marcus; Miller, Patrick; Cotogno, Patrick; Layton, Jodi; Barata, Pedro; Lewis, Brian E; Nakazawa, Mari; Zhu, Jason; Dellinger, Beth; Elrefai, Sara; Nafissi, Nellie N; Egan, Jan B; Shore, Neal; McKay, Rana R; Bryce, Alan H; Cheng, Heather H; Antonarakis, Emmanuel S; Sartor, Oliver.
Affiliation
  • Ledet EM; Department of Medicine, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
  • Burgess EF; Genitourinary Oncology Section, Levine Cancer Institute/Atrium Health, Charlotte, North Carolina, USA.
  • Sokolova AO; Division of Oncology, Department of Medicine, University of Washington Medical Center/Fred Hutchinson Cancer Research Center/VA Puget Sound HCS, Seattle, Washington, USA.
  • Jaeger EB; Department of Medicine, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
  • Hatton W; Department of Medicine, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
  • Moses M; School of Medicine, Tulane University, New Orleans, Louisiana, USA.
  • Miller P; Department of Medicine, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
  • Cotogno P; Department of Medicine, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
  • Layton J; Department of Medicine, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
  • Barata P; Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
  • Lewis BE; Department of Medicine, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
  • Nakazawa M; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland, USA.
  • Zhu J; Genitourinary Oncology Section, Levine Cancer Institute/Atrium Health, Charlotte, North Carolina, USA.
  • Dellinger B; Genitourinary Oncology Section, Levine Cancer Institute/Atrium Health, Charlotte, North Carolina, USA.
  • Elrefai S; Genitourinary Oncology Section, Levine Cancer Institute/Atrium Health, Charlotte, North Carolina, USA.
  • Nafissi NN; Internal Medicine, Mayo Clinic, Phoenix, Arizona, USA.
  • Egan JB; Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, USA.
  • Shore N; Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, South Carolina, USA.
  • McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, California, USA.
  • Bryce AH; Division of Hematology/Oncology, Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, Arizona, USA.
  • Cheng HH; Division of Oncology, Department of Medicine, University of Washington Medical Center/Fred Hutchinson Cancer Research Center/VA Puget Sound HCS, Seattle, Washington, USA.
  • Antonarakis ES; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland, USA.
  • Sartor O; Department of Medicine, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
Prostate ; 81(7): 433-439, 2021 05.
Article de En | MEDLINE | ID: mdl-33792945

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / / Mutation germinale / Protéine BRCA2 / / Métastase tumorale Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Male / Middle aged Langue: En Journal: Prostate Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / / Mutation germinale / Protéine BRCA2 / / Métastase tumorale Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Male / Middle aged Langue: En Journal: Prostate Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique